BRIEF — Lakefront Announces Sale Of Preclinical Car — T Programs To Armed Cell Therapeutics
Oct 14 (Reuters) — Lakefront Biotherapeutics NV: Lakefront Announces Sale Of Preclinical Car-t Programs To Armed Cell Therapeutics Lakefront Biotherapeutics Nv: Armed Cell Therapeutics To Independently Advance Bought Cell Therapy Programs Lakefront Biotherapeutics Nv: Terms Of Deal Include Upfront Payment Of Eur 8 Mill